Biological Sensors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Heart Rate Monitoring Sensors, Brain Wave Sensors, Sweat Gland Activity Sensors, Breathing Rate Monitoring Sensors, Others), By Product Type (Embedded Device, Sensor Patch), By Application (Diagnostic, Monitoring, Therapeutic), By Region, and By Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 31.72 Billion
CAGR (2026-2031)	8.12%
Fastest Growing Segment	Heart Rate Monitoring Sensors
Largest Market	North America
Market Size (2031)	USD 50.67 Billion

Market Overview

The Global Biological Sensors Market will grow from USD 31.72 Billion in 2025 to USD 50.67 Billion by 2031 at a 8.12% CAGR. Biological sensors are analytical devices that integrate a biological recognition element with a physicochemical transducer to detect specific analytes. These instruments primarily facilitate the monitoring of physiological data and environmental parameters by converting biological responses into measurable signals. The market is fundamentally driven by the escalating global prevalence of chronic lifestyle diseases which necessitates continuous and accurate physiological monitoring. Furthermore, the rising demand for testing at the point of care supports market growth by shifting diagnostics from centralized laboratories to patient settings and reducing turnaround times for critical medical decisions.

According to the International Diabetes Federation, in 2024, approximately 589 million adults were living with diabetes globally. This substantial patient population underscores the critical urgency for accessible glucose monitoring technologies which represent a dominant segment of the industry. Despite this demand, the market faces a significant impediment regarding stringent regulatory frameworks governing medical device approval. The complex nature of obtaining certification from major health authorities creates high barriers to entry and delays the commercialization of novel sensing platforms.

Key Market Drivers

The increasing prevalence of chronic and lifestyle-associated diseases acts as the primary catalyst for the Global Biological Sensors Market, fundamentally altering patient management strategies. Conditions such as diabetes and cardiovascular disorders require rigorous, continuous physiological tracking, necessitating the adoption of high-performance biosensing platforms that provide real-time metabolic data rather than episodic measurements. This escalation in disease burden directly correlates with the surging commercial volume of continuous glucose monitoring (CGM) systems, which currently serve as the sector's revenue backbone by replacing traditional invasive methods. For instance, according to Abbott, October 2024, in the 'Third-Quarter 2024 Financial Results', the company's Diabetes Care sales exceeded $1.6 billion, driven substantially by the global uptake of their biosensor-based FreeStyle Libre portfolio.

Simultaneously, the surge in demand for point-of-care and home-based diagnostics is reshaping the industry landscape by decentralizing healthcare delivery. Patients and providers increasingly prioritize accessible, non-invasive devices that allow for autonomous health management outside of traditional clinical settings, thereby reducing hospital visits and associated costs. This trend is further accelerated by regulatory approvals for over-the-counter access to sensing technologies, effectively democratizing access to critical biometric data. According to Dexcom, October 2024, in the 'Third Quarter 2024 Financial Results', worldwide revenue reached $994.2 million, reflecting the massive consumer adoption of these home-based analytical tools. To sustain this innovation pipeline, according to Penn State University, October 2024, in the article '$1.5M NSF grant to launch AI-designed biosensor research project', the National Science Foundation awarded a $1.5 million grant to develop AI-designed biosensors, highlighting the role of research funding in expanding market capabilities.

Download Free Sample Report

Key Market Challenges

The global biological sensors market is currently grappling with the significant obstacle of navigating increasingly stringent regulatory environments. Health authorities worldwide have implemented rigorous compliance standards to ensure patient safety, but these measures have inadvertently created substantial barriers for manufacturers. The complex and lengthy certification processes required for new medical devices force companies to allocate extensive resources toward compliance rather than innovation. This regulatory burden creates a bottleneck that delays the introduction of advanced sensing technologies to the market, thereby slowing the overall industry expansion and limiting patient access to critical diagnostic tools.

These procedural complexities directly impact the financial viability and operational timelines of market participants. Small and medium-sized enterprises are particularly vulnerable, as they often lack the capital to sustain prolonged approval cycles. The inefficiency of these frameworks is evident in recent industry assessments regarding certification timelines. According to MedTech Europe, in 2024, over 50% of the total time required for the conformity assessment of medical devices was consumed by administrative phases outside of the actual scientific review. This statistic highlights the magnitude of the inefficiency, demonstrating how non-technical bureaucratic hurdles are effectively stalling the commercialization of essential biological sensor platforms.

Key Market Trends

The development of multiplexing capabilities for simultaneous detection enables the identification of multiple analytes within a single testing protocol, significantly enhancing diagnostic efficiency. This trend is particularly vital for managing co-infections and complex disease states where traditional single-analyte sensors are insufficient. By leveraging advanced electrochemical and molecular recognition elements, researchers are producing compact devices that streamline clinical workflows and reduce the biological sample volume required. This technological progression is exemplified by recent funding initiatives for multi-viral detection platforms. According to Contagion Live, October 2025, in the 'UCF Team Advances Low-Cost Multiplex RNA Test for HIV, HBV, and HCV' article, the University of Central Florida received a $537,619 grant to develop a low-cost assay capable of simultaneously detecting HIV, Hepatitis B, and Hepatitis C.

Concurrently, the introduction of biodegradable and eco-friendly sensor materials is redefining the lifecycle of diagnostic devices to address the growing concern of medical electronic waste. This innovation focuses on engineering transient biosensors using natural polymers and hydrogels that maintain high functionality before safely decomposing. These sustainable materials are proving to be highly effective, offering sensitivity levels that rival or exceed those of conventional synthetic counterparts. For instance, according to Lab Manager, September 2025, in the 'Biodegradable Health Sensors Outperform Conventional Synthetic Sensors' article, researchers from the University of Sussex developed a graphene-algae hydrogel sensor capable of detecting an object with a mass of just 2mg, demonstrating the viability of green technologies in high-precision monitoring.

Segmental Insights

Heart rate monitoring sensors represent the fastest-growing segment within the global biological sensors market due to the widespread adoption of wearable health technology. This expansion is primarily driven by the rising prevalence of cardiovascular conditions which necessitates continuous and non-invasive tracking for preventive healthcare. Furthermore, regulatory bodies such as the U.S. FDA have increasingly cleared consumer wearables for clinical-grade monitoring which validates their utility in chronic disease management. This regulatory support facilitates the integration of these sensors into daily life and encourages widespread market demand for accessible personal health monitoring solutions.

Regional Insights

North America holds the leading position in the global biological sensors market due to extensive investments in medical research and a robust healthcare infrastructure. The region benefits from the concentration of key industry players and consistent government funding for technology development. Additionally, the increasing need for chronic disease management drives the adoption of diagnostic tools. Support from institutions like the National Science Foundation and clear regulatory guidelines from the U.S. Food and Drug Administration facilitate rapid product commercialization. These combined factors secure the region's market leadership without relying on temporary trends.

Recent Developments

• In February 2025, The Cultivated B launched a new line of AI-driven, multi-channel biosensors engineered for the precise monitoring of cell culture and fermentation processes. The biotechnology company introduced this innovation to empower bioprocess engineers with real-time analytics and continuous tracking of metabolic parameters, such as glucose and amino acids, with high sensitivity. The biosensors were designed to eliminate the need for manual sampling, thereby reducing contamination risks and optimizing production efficiency in industrial settings. This development represented a technical advancement in the industrial biosensors segment, offering tools to accelerate the scaling of complex biotechnology applications.
• In November 2024, Dexcom announced a strategic partnership and a $75 million investment in Oura, a company specializing in smart ring technology. The collaboration was formed to integrate glucose data from Dexcom’s biosensors with the vital sign metrics collected by the Oura Ring, such as sleep quality, heart rate, and activity levels. By combining these distinct biometric data streams, the companies aimed to provide users with a comprehensive view of the relationship between lifestyle factors and blood sugar regulation. This initiative was designed to enhance metabolic health insights and allow for the seamless flow of glucose information into the Oura mobile platform.
• In September 2024, Abbott launched Lingo, its first over-the-counter continuous glucose monitoring system available to consumers in the U.S. without a prescription. Built on the company's established FreeStyle Libre sensing technology, the biowearable device and accompanying mobile application were designed for adults not taking insulin who seek to improve their overall health and wellness. The system provided users with real-time data and personalized coaching to track glucose spikes and understand how their metabolism responds to food, exercise, and sleep. This product launch marked a significant strategic expansion for the company into the broader consumer health and wellness market.
• In August 2024, Medtronic received FDA approval for its Simplera continuous glucose monitor (CGM), a disposable, all-in-one device designed to be half the size of its predecessors. Coinciding with this regulatory milestone, the medical technology leader announced a global partnership with Abbott to develop an integrated CGM based on Abbott’s sensor platform. This collaboration was established to expand access to advanced automated insulin delivery and smart dosing systems by incorporating Abbott's widely used sensing technology. Under the agreement, the new integrated sensor would be sold exclusively by Medtronic, aiming to streamline diabetes management for patients requiring intensive insulin therapy.

Key Market Players

• Epicore Biosystems, Inc.
• GraphWear Technologies Inc.
• Kenzen Inc.
• Rohm Co., Ltd.
• Qardio Inc.
• iRhythm Technologies, Inc.
• Masimo Corporation
• Celte S.p.a.
• Omron Corporation
• Koninklijke Philips N.V.

By Product Type	By Application	By Region
Embedded Device Sensor Patch	Diagnostic Monitoring Therapeutic	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Biological Sensors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Biological Sensors Market, By Product Type:

• Embedded Device
• Sensor Patch

• Biological Sensors Market, By Application:

• Diagnostic
• Monitoring
• Therapeutic

• Biological Sensors Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE